Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes may be less welcome. Here's what to expect.
GenBioPro, a leading manufacturer of abortion medication, is preparing to go to battle with the Trump administration.
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
Baltimore Ravens general manager Eric DeCosta has called the allegations and the number of allegations of inappropriate ...
Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth ...
The industry wants the ability to make bolder health claims and to get the government and private insurers to pay for its products — as they do FDA-approved drugs.
Officials took the 34 people who completed the program as a win, arguing that overcoming addiction is no easy task.
Top medics have issued urgent warnings after fat jabs including celebrity favourite Ozempic are inked with 82 deaths, as drug ...
Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...
In partnership with Sekisui Diagnostics, the company and its distribution partners have made the test available across the US ...
Defendant Pedro Hernandez "paid the price for flooding our community with dangerous narcotics," the D.A. said.
Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback